Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program

1. Bernabé-Caro, R.
2. Garrido, P.
3. García-Campelo, R.
4. Palmero, R.
5. Artal, Á.
6. Bayona, C.
7. Rodríguez-Abreu, D.
8. López-Brea, M.
9. Paredes, A.
10. Vicente, D.
11. Torres, J.M.S.
12. Majem, M.
13. Diz, P.
14. Gordo, R.
15. Coca, M.
16. de Castro, J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.18632/ONCOTARGET.28244 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus